Welcome to our dedicated page for GLOBE LIFE SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
Globe Life Inc. filed a Form 13F reporting its institutional holdings as manager, showing 2 reported positions with a total reported market value of $400,198,817. The report was signed by Christopher T. Moore on 11-07-2025.
Globe Life Inc. amended its Supplemental Executive Retirement Plan (SERP). The update revises the early retirement reduction factors, setting benefit levels from 50% at age 55 up to 100% at age 65.
The amendment also provides that SERP participants who are in the Executive Severance Plan and experience a “Qualifying Termination” during a “Change of Control Protection Period” will be deemed vested and eligible for Retirement Income. In that case, the participant’s retirement age is deemed the greater of actual age or 55; the Pension Plan benefit is assumed vested, early-retirement eligible, and calculated as of the greater of actual age or 55; and no additional Credited service is included in either the Pension Plan or SERP benefit.
Globe Life Inc. filed its quarterly report for the period ended September 30, 2025. The filing presents a larger balance sheet, reflecting growth in invested assets and liquidity.
All dollar amounts are in thousands. Total assets were $30,527,616 versus $29,076,181 at December 31, 2024. Total investments were $20,326,714, up from $19,571,563, including fixed maturities at fair value of $17,796,754 (amortized cost: 2025—$18,948,357; allowance for credit losses: 2025—$10,415). Cash was $302,716, compared with $165,325.
Total liabilities were $24,838,528 versus $23,770,661. Policy liabilities were $20,626,749, up from $19,716,330, including future policy benefits at current discount rates of $19,301,965. Short‑term debt was $394,349 and long‑term debt was $2,320,013 (estimated fair value: 2025—$2,196,342).
As context, common shares outstanding were 79,605,800 as of October 31, 2025.
Globe Life Inc. (GL) reported an insider transaction by EVP, General Counsel and CRO Robert Brian Mitchell on 10/24/2025. He exercised employee stock options at $100.74, $98.32 and $103.23, acquiring 38,000, 38,000 and 15,000 shares of common stock. He then sold 40,185 shares at an average price of $133.8686 and 50,815 shares at an average price of $134.5964.
Following these transactions, his direct ownership was 8,074 shares. Indirect holdings were 41,133.3294 shares in the Mitchell Family Trust, 1,580.7839 shares in a Son's Trust, and 12,274.832 shares in a 401(k) Plan.
Globe Life (GL) filed a Form 144 notice for a proposed sale of 91,000 shares of common stock. The filing lists Apex Clearing as broker, with sales on the NYSE and an approximate sale date of 10/24/2025. The filing states an aggregate market value of $12,338,690 for the proposed sale. The seller acquired these shares via stock option exercise on 02/24/2021. Shares outstanding were 79,917,082 at the time noted; this is a baseline figure, not the amount being sold.
Globe Life Inc. (GL) furnished an 8-K announcing its third quarter 2025 results. The company issued a press release on October 22, 2025, and attached it as Exhibit 99.1.
The disclosure under Item 2.02 (Results of Operations and Financial Condition) is provided pursuant to General Instruction B.2 and is deemed “furnished,” not “filed” under the Exchange Act, which limits its incorporation into other filings absent specific reference.
The filing also lists Exhibit 104 (Cover Page Interactive Data File). No specific financial figures are included in this report; details reside in the press release.
Dolores L. Skarjune, EVP and Chief Administrative Officer of Globe Life Inc. (GL), reported option exercises and a sale on 09/12/2025. She exercised options to acquire 2,100 shares at $82.56 and 2,400 shares at $98.32, and sold 4,500 shares at $142.52. Following these transactions she directly beneficially owns 9,417 shares and indirectly holds 2,701.527 shares through a 401(k) plan, for a combined reported position of 13,917 shares.
Form 144 filed for Globe Life Inc. (GL) reports an intended sale of 4,500 shares of common stock through APEX CLEARING on the NYSE with an aggregate market value of $641,205 and an approximate sale date of 09/12/2025. The shares were acquired by the seller from Globe Life via stock option exercises on 02/28/2019 (2,100 shares) and 02/24/2021 (2,400 shares); the payment source for the sale is listed as proceeds of stock option exercise. The filing also discloses a sale on 09/10/2025 of 4,974 shares generating gross proceeds of $695,532.32. The filer attests not to possess undisclosed material adverse information.
Dolores L. Skarjune, Executive Vice President and Chief Administrative Officer of Globe Life Inc. (GL), reported multiple transactions dated 09/10/2025. She exercised an employee stock option to acquire 6,200 shares at an exercise price of $103.23 per share. On the same date she sold 3,354 shares at prices ranging from $139.31 to $140.01 and sold an additional 1,620 shares at prices ranging from $140.015 to $140.49. After these transactions she beneficially owned 11,037 shares directly and 2,701.527 shares indirectly through a 401(k) plan. The Form 4 was signed by an attorney-in-fact on 09/11/2025.
Globe Life Inc. Form 144 filing for proposed sale of common stock. The notice reports an intended sale of 6,200 shares of Globe Life common stock through APEX CLEARING on the NYSE with an aggregate market value of $870,852 and approximately 80,432,773 shares outstanding. The shares were acquired on 02/23/2022 via a stock option exercise from Globe Life Inc., and the proposed sale date is 09/10/2025. The filer states there were no sales by the same person in the past three months and includes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.